By William Sumner, Hemp Business Journal Contributor

Last week, the hemp industry was abuzz with the news that the DEA would move Epidiolex from a Schedule I substance to a Schedule V substance. Many have taken the news as a positive signal for the hemp market, and investors are already lining up to get a piece of the emerging market. In this summary, the Hemp Business Journal looks at some leading public hemp companies to provide a rundown about their latest happenings.

It’s a giddy time for the U.S. hemp industry. Farmers are planting more acres. Businesses are selling more products. And with Congress on the brink of fully legalizing hemp, industry insiders are eagerly anticipating a boom. But even if the legalization provisions in the 2018 farm bill pass, hemp will remain a tightly regulated crop facing plenty of regulatory and legal challenges. Read More

stores.specialty and will be available to US consumers in over 2,400 natural says has introduced its new hemp beverage and supplement line, Oki, to mainstream retailers in the US. The beverages and supplements are infused with active hemp extract, the company Phivida Read More

• Market Sizes (Hemp, MJ, Pharma)
• Medical Survey Data
• Strategy, Analysis and Insights
• Natural Products Industry
• Canadian M&A Activity
• And much, much, more….

Stay abreast of critical industry news, curated and sent to your inbox daily